149 related articles for article (PubMed ID: 2893198)
1. Risk estimation and screening in families of patients with medullary thyroid carcinoma.
Ponder BA; Ponder MA; Coffey R; Pembrey ME; Gagel RF; Telenius-Berg M; Semple P; Easton DF
Lancet; 1988 Feb; 1(8582):397-401. PubMed ID: 2893198
[TBL] [Abstract][Full Text] [Related]
2. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
3. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
4. Family screening in medullary thyroid carcinoma presenting without a family history.
Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.
Vasen HF; Nieuwenhuijzen Kruseman AC; Berkel H; Beukers EK; Delprat CC; Van Doorn RG; Geerdink RA; Haak HR; Hackeng WH; Koppeschaar HP
Am J Med; 1987 Nov; 83(5):847-52. PubMed ID: 2890300
[TBL] [Abstract][Full Text] [Related]
6. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
[TBL] [Abstract][Full Text] [Related]
7. [Multiple endocrine neoplasia type 2: familial variant of medullary carcinoma of the thyroid gland].
Neradilová M; Soutorová M; Vlcek P
Vnitr Lek; 1992 Sep; 38(9):850-9. PubMed ID: 1362306
[TBL] [Abstract][Full Text] [Related]
8. [Familial studies in medullary thyroid carcinoma and multiple endocrine adenomatosis].
Woodtli W; Ziegler WH; Dambacher MA
Schweiz Med Wochenschr; 1982 Dec; 112(49):1780-4. PubMed ID: 6129697
[TBL] [Abstract][Full Text] [Related]
9. [Endocrine polyadenomatosis of 2a type (MEN 2a). Clinical and genetic study of a family].
Guillausseau PJ; Guillausseau C; Calmettes C; Feingold N; Demenais F; Sobol H; Gony J; Hors J; Schaison G; Seret D
Ann Endocrinol (Paris); 1988; 49(1):17-21. PubMed ID: 2900619
[TBL] [Abstract][Full Text] [Related]
10. Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment.
Emmertsen K; Elbrønd O; Nielsen HE; Mosekilde L; Charles P; Kaae S; Hansen HH
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):645-50. PubMed ID: 6127216
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 2A (MEN-2A): natural history, screening, and central registration.
Brouwers-Smalbraak GJ; Vasen HF; Struyvenberg A; Nieuwenhuijzen Kruseman AC; Helsloot MH; Lips CJ
Neth J Med; 1986; 29(4):111-7. PubMed ID: 2872602
[No Abstract] [Full Text] [Related]
12. Characteristics of a family with the MEN-2A syndrome.
Haak HR; Nieuwenhuijzen Kruseman AC
Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639
[No Abstract] [Full Text] [Related]
13. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinoma: Australian experience with genetic testing.
Ward JL; Hyland VJ; Andrew DS; Marsh DJ; Robinson BG
Henry Ford Hosp Med J; 1992; 40(3-4):220-3. PubMed ID: 1362409
[TBL] [Abstract][Full Text] [Related]
15. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
[TBL] [Abstract][Full Text] [Related]
16. The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.
Frilling A; Goretzki PE; Bastian L; Roeher HD
Henry Ford Hosp Med J; 1989; 37(3-4):122-3. PubMed ID: 2576942
[TBL] [Abstract][Full Text] [Related]
17. [A family with type 2a multiple endocrine neoplasms].
Haak HR; Vierhout PA; Vink M; Nieuwenhuyzen Kruseman AC
Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1660-4. PubMed ID: 2902520
[No Abstract] [Full Text] [Related]
18. [The genetics of medullary cancer of the thyroid].
Ponder BA; Easton DF; Mathew CG
Ann Endocrinol (Paris); 1988; 49(1):4-9. PubMed ID: 2900621
[TBL] [Abstract][Full Text] [Related]
19. [Multiple endocrine neoplasia II A syndrome: relationship between age of the patient, levels of basal calcitonin and size of the thyroid tumor].
Parrilla P; Candel MF; Ponce JL; Tebar J; Albarracin A; Rodriguez JM
Minerva Chir; 1992 May; 47(9):831-8. PubMed ID: 1352395
[TBL] [Abstract][Full Text] [Related]
20. [A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer].
Rochiccioli P; Tauber MT; Pienkowski C
J Genet Hum; 1989 Sep; 37(3):207-14. PubMed ID: 2576280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
